Lombard Odier Asset Management Switzerland SA Acquires New Stake in HCA Healthcare, Inc. $HCA

Lombard Odier Asset Management Switzerland SA purchased a new position in HCA Healthcare, Inc. (NYSE:HCA) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 4,037 shares of the company’s stock, valued at approximately $1,910,000.

Other institutional investors have also recently made changes to their positions in the company. Brighton Jones LLC purchased a new position in HCA Healthcare in the fourth quarter worth about $1,021,000. NewEdge Advisors LLC lifted its stake in shares of HCA Healthcare by 11.9% in the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after purchasing an additional 409 shares during the period. Sivia Capital Partners LLC grew its position in HCA Healthcare by 5.5% during the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after buying an additional 33 shares during the period. Jump Financial LLC bought a new position in HCA Healthcare in the second quarter worth approximately $2,073,000. Finally, Sei Investments Co. increased its stake in shares of HCA Healthcare by 56.3% in the 2nd quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock worth $52,328,000 after purchasing an additional 49,214 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Trending Headlines about HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA beat Q2 earnings estimates, reporting $7.59 per share versus expectations around $7.56-$7.57, while revenue rose 8.7% year over year to $20.23 billion and also topped estimates. HCA Healthcare earnings report
• Positive Sentiment: Management cited strong admissions and higher revenue per admission as key drivers of the quarter, suggesting healthy demand trends across its hospital network. Zacks article on HCA Q2 results
• Neutral Sentiment: HCA said its updated guidance is consistent with its earlier preview, so the quarter appears to confirm previously signaled results rather than deliver a major surprise. BusinessWire Q2 results
• Negative Sentiment: The company trimmed parts of its 2026 outlook, pointing to higher expenses and weaker surgical volumes as headwinds that could limit margin expansion. Zacks guidance revision article
• Negative Sentiment: Separate investor-law-firm investigations into HCA may add some legal overhang, though these notices are not operational results. Pomerantz investor alert

HCA Healthcare Trading Up 0.0%

Shares of NYSE:HCA opened at $382.28 on Monday. The firm’s 50-day moving average is $386.95 and its 200 day moving average is $453.56. HCA Healthcare, Inc. has a 12 month low of $330.00 and a 12 month high of $556.52. The company has a market capitalization of $84.80 billion, a price-to-earnings ratio of 12.80, a PEG ratio of 1.29 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping the consensus estimate of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business had revenue of $20.23 billion during the quarter, compared to analysts’ expectations of $19.76 billion. During the same period in the prior year, the business earned $6.84 EPS. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. As a group, equities analysts forecast that HCA Healthcare, Inc. will post 29.19 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare’s payout ratio is presently 10.45%.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on HCA. Argus lowered their price objective on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a research report on Monday, May 4th. Robert W. Baird lowered their price target on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. Wells Fargo & Company set a $369.00 price objective on shares of HCA Healthcare in a research note on Monday, July 20th. KeyCorp dropped their target price on shares of HCA Healthcare from $510.00 to $475.00 and set an “overweight” rating for the company in a report on Tuesday, July 14th. Finally, Oppenheimer decreased their price target on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Fourteen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average price target of $483.45.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.